Global Monoclonal Antibody ADC Drugs Market Growth 2022-2028
The global market for Monoclonal Antibody ADC Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Monoclonal Antibody ADC Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Monoclonal Antibody ADC Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Monoclonal Antibody ADC Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Monoclonal Antibody ADC Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Monoclonal Antibody ADC Drugs players cover Seattle, Roche, Pfizer, AstraZeneca and Immunomedics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Monoclonal Antibody ADC Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Monoclonal Antibody ADC Drugs market, with both quantitative and qualitative data, to help readers understand how the Monoclonal Antibody ADC Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Monoclonal Antibody ADC Drugs market and forecasts the market size by Type (CD30 Target Antigen, HER2 Target Antigen and CD22 Target Antigen), by Application (Lymphoma, Breast Cancer, Leukemia and Myeloma), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
CD30 Target Antigen
HER2 Target Antigen
CD22 Target Antigen
CD33 Target Antigen
Nectin-4 Target Antigen
Others
Segmentation by application
Lymphoma
Breast Cancer
Leukemia
Myeloma
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Seattle
Roche
Pfizer
AstraZeneca
Immunomedics
GSK
ADC Therapeutics
Chapter Introduction
Chapter 1: Scope of Monoclonal Antibody ADC Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Monoclonal Antibody ADC Drugs market size (sales and revenue) and CAGR, Monoclonal Antibody ADC Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Monoclonal Antibody ADC Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Monoclonal Antibody ADC Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Monoclonal Antibody ADC Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Seattle, Roche, Pfizer, AstraZeneca, Immunomedics, GSK and ADC Therapeutics, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Monoclonal Antibody ADC Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Monoclonal Antibody ADC Drugs by Country/Region, 2017, 2022 & 2028
2.2 Monoclonal Antibody ADC Drugs Segment by Type
2.2.1 CD30 Target Antigen
2.2.2 HER2 Target Antigen
2.2.3 CD22 Target Antigen
2.2.4 CD33 Target Antigen
2.2.5 Nectin-4 Target Antigen
2.2.6 Others
2.3 Monoclonal Antibody ADC Drugs Sales by Type
2.3.1 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Monoclonal Antibody ADC Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Monoclonal Antibody ADC Drugs Sale Price by Type (2017-2022)
2.4 Monoclonal Antibody ADC Drugs Segment by Application
2.4.1 Lymphoma
2.4.2 Breast Cancer
2.4.3 Leukemia
2.4.4 Myeloma
2.4.5 Others
2.5 Monoclonal Antibody ADC Drugs Sales by Application
2.5.1 Global Monoclonal Antibody ADC Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Monoclonal Antibody ADC Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Monoclonal Antibody ADC Drugs Sale Price by Application (2017-2022)
3 Global Monoclonal Antibody ADC Drugs by Company
3.1 Global Monoclonal Antibody ADC Drugs Breakdown Data by Company
3.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Company (2020-2022)
3.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Company (2020-2022)
3.2.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Monoclonal Antibody ADC Drugs Sale Price by Company
3.4 Key Manufacturers Monoclonal Antibody ADC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monoclonal Antibody ADC Drugs Product Location Distribution
3.4.2 Players Monoclonal Antibody ADC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Monoclonal Antibody ADC Drugs by Geographic Region
4.1 World Historic Monoclonal Antibody ADC Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Geographic Region
4.2 World Historic Monoclonal Antibody ADC Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Monoclonal Antibody ADC Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Monoclonal Antibody ADC Drugs Annual Revenue by Country/Region
4.3 Americas Monoclonal Antibody ADC Drugs Sales Growth
4.4 APAC Monoclonal Antibody ADC Drugs Sales Growth
4.5 Europe Monoclonal Antibody ADC Drugs Sales Growth
4.6 Middle East & Africa Monoclonal Antibody ADC Drugs Sales Growth
5 Americas
5.1 Americas Monoclonal Antibody ADC Drugs Sales by Country
5.1.1 Americas Monoclonal Antibody ADC Drugs Sales by Country (2017-2022)
5.1.2 Americas Monoclonal Antibody ADC Drugs Revenue by Country (2017-2022)
5.2 Americas Monoclonal Antibody ADC Drugs Sales by Type
5.3 Americas Monoclonal Antibody ADC Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monoclonal Antibody ADC Drugs Sales by Region
6.1.1 APAC Monoclonal Antibody ADC Drugs Sales by Region (2017-2022)
6.1.2 APAC Monoclonal Antibody ADC Drugs Revenue by Region (2017-2022)
6.2 APAC Monoclonal Antibody ADC Drugs Sales by Type
6.3 APAC Monoclonal Antibody ADC Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Monoclonal Antibody ADC Drugs by Country
7.1.1 Europe Monoclonal Antibody ADC Drugs Sales by Country (2017-2022)
7.1.2 Europe Monoclonal Antibody ADC Drugs Revenue by Country (2017-2022)
7.2 Europe Monoclonal Antibody ADC Drugs Sales by Type
7.3 Europe Monoclonal Antibody ADC Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Monoclonal Antibody ADC Drugs by Country
8.1.1 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Type
8.3 Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monoclonal Antibody ADC Drugs
10.3 Manufacturing Process Analysis of Monoclonal Antibody ADC Drugs
10.4 Industry Chain Structure of Monoclonal Antibody ADC Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Monoclonal Antibody ADC Drugs Distributors
11.3 Monoclonal Antibody ADC Drugs Customer
12 World Forecast Review for Monoclonal Antibody ADC Drugs by Geographic Region
12.1 Global Monoclonal Antibody ADC Drugs Market Size Forecast by Region
12.1.1 Global Monoclonal Antibody ADC Drugs Forecast by Region (2023-2028)
12.1.2 Global Monoclonal Antibody ADC Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Monoclonal Antibody ADC Drugs Forecast by Type
12.7 Global Monoclonal Antibody ADC Drugs Forecast by Application
13 Key Players Analysis
13.1 Seattle
13.1.1 Seattle Company Information
13.1.2 Seattle Monoclonal Antibody ADC Drugs Product Offered
13.1.3 Seattle Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Seattle Main Business Overview
13.1.5 Seattle Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Monoclonal Antibody ADC Drugs Product Offered
13.2.3 Roche Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Monoclonal Antibody ADC Drugs Product Offered
13.3.3 Pfizer Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Monoclonal Antibody ADC Drugs Product Offered
13.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Immunomedics
13.5.1 Immunomedics Company Information
13.5.2 Immunomedics Monoclonal Antibody ADC Drugs Product Offered
13.5.3 Immunomedics Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Immunomedics Main Business Overview
13.5.5 Immunomedics Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Monoclonal Antibody ADC Drugs Product Offered
13.6.3 GSK Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 ADC Therapeutics
13.7.1 ADC Therapeutics Company Information
13.7.2 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Offered
13.7.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 ADC Therapeutics Main Business Overview
13.7.5 ADC Therapeutics Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Monoclonal Antibody ADC Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Monoclonal Antibody ADC Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of CD30 Target Antigen
Table 4. Major Players of HER2 Target Antigen
Table 5. Major Players of CD22 Target Antigen
Table 6. Major Players of CD33 Target Antigen
Table 7. Major Players of Nectin-4 Target Antigen
Table 8. Major Players of Others
Table 9. Global Monoclonal Antibody ADC Drugs Sales by Type (2017-2022) & (K Units)
Table 10. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2017-2022)
Table 11. Global Monoclonal Antibody ADC Drugs Revenue by Type (2017-2022) & ($ million)
Table 12. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2017-2022)
Table 13. Global Monoclonal Antibody ADC Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Monoclonal Antibody ADC Drugs Sales by Application (2017-2022) & (K Units)
Table 15. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2017-2022)
Table 16. Global Monoclonal Antibody ADC Drugs Revenue by Application (2017-2022)
Table 17. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2017-2022)
Table 18. Global Monoclonal Antibody ADC Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Monoclonal Antibody ADC Drugs Sales by Company (2020-2022) & (K Units)
Table 20. Global Monoclonal Antibody ADC Drugs Sales Market Share by Company (2020-2022)
Table 21. Global Monoclonal Antibody ADC Drugs Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company (2020-2022)
Table 23. Global Monoclonal Antibody ADC Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Monoclonal Antibody ADC Drugs Producing Area Distribution and Sales Area
Table 25. Players Monoclonal Antibody ADC Drugs Products Offered
Table 26. Monoclonal Antibody ADC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Monoclonal Antibody ADC Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Monoclonal Antibody ADC Drugs Sales Market Share Geographic Region (2017-2022)
Table 31. Global Monoclonal Antibody ADC Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Monoclonal Antibody ADC Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Monoclonal Antibody ADC Drugs Sales Market Share by Country/Region (2017-2022)
Table 35. Global Monoclonal Antibody ADC Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Monoclonal Antibody ADC Drugs Sales by Country (2017-2022) & (K Units)
Table 38. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Country (2017-2022)
Table 39. Americas Monoclonal Antibody ADC Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2017-2022)
Table 41. Americas Monoclonal Antibody ADC Drugs Sales by Type (2017-2022) & (K Units)
Table 42. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Type (2017-2022)
Table 43. Americas Monoclonal Antibody ADC Drugs Sales by Application (2017-2022) & (K Units)
Table 44. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Application (2017-2022)
Table 45. APAC Monoclonal Antibody ADC Drugs Sales by Region (2017-2022) & (K Units)
Table 46. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Region (2017-2022)
Table 47. APAC Monoclonal Antibody ADC Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2017-2022)
Table 49. APAC Monoclonal Antibody ADC Drugs Sales by Type (2017-2022) & (K Units)
Table 50. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Type (2017-2022)
Table 51. APAC Monoclonal Antibody ADC Drugs Sales by Application (2017-2022) & (K Units)
Table 52. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Application (2017-2022)
Table 53. Europe Monoclonal Antibody ADC Drugs Sales by Country (2017-2022) & (K Units)
Table 54. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country (2017-2022)
Table 55. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2017-2022)
Table 57. Europe Monoclonal Antibody ADC Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Type (2017-2022)
Table 59. Europe Monoclonal Antibody ADC Drugs Sales by Application (2017-2022) & (K Units)
Table 60. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Monoclonal Antibody ADC Drugs
Table 70. Key Market Challenges & Risks of Monoclonal Antibody ADC Drugs
Table 71. Key Industry Trends of Monoclonal Antibody ADC Drugs
Table 72. Monoclonal Antibody ADC Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Monoclonal Antibody ADC Drugs Distributors List
Table 75. Monoclonal Antibody ADC Drugs Customer List
Table 76. Global Monoclonal Antibody ADC Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Monoclonal Antibody ADC Drugs Sales Market Forecast by Region
Table 78. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Monoclonal Antibody ADC Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Monoclonal Antibody ADC Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Monoclonal Antibody ADC Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Monoclonal Antibody ADC Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Monoclonal Antibody ADC Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Monoclonal Antibody ADC Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Monoclonal Antibody ADC Drugs Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Monoclonal Antibody ADC Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Monoclonal Antibody ADC Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 96. Seattle Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Seattle Monoclonal Antibody ADC Drugs Product Offered
Table 98. Seattle Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. Seattle Main Business
Table 100. Seattle Latest Developments
Table 101. Roche Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Roche Monoclonal Antibody ADC Drugs Product Offered
Table 103. Roche Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. Roche Main Business
Table 105. Roche Latest Developments
Table 106. Pfizer Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Monoclonal Antibody ADC Drugs Product Offered
Table 108. Pfizer Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. AstraZeneca Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. AstraZeneca Monoclonal Antibody ADC Drugs Product Offered
Table 113. AstraZeneca Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. AstraZeneca Main Business
Table 115. AstraZeneca Latest Developments
Table 116. Immunomedics Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Immunomedics Monoclonal Antibody ADC Drugs Product Offered
Table 118. Immunomedics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Immunomedics Main Business
Table 120. Immunomedics Latest Developments
Table 121. GSK Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. GSK Monoclonal Antibody ADC Drugs Product Offered
Table 123. GSK Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. GSK Main Business
Table 125. GSK Latest Developments
Table 126. ADC Therapeutics Basic Information, Monoclonal Antibody ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. ADC Therapeutics Monoclonal Antibody ADC Drugs Product Offered
Table 128. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. ADC Therapeutics Main Business
Table 130. ADC Therapeutics Latest Developments
List of Figures
Figure 1. Picture of Monoclonal Antibody ADC Drugs
Figure 2. Monoclonal Antibody ADC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Monoclonal Antibody ADC Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Monoclonal Antibody ADC Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Monoclonal Antibody ADC Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of CD30 Target Antigen
Figure 10. Product Picture of HER2 Target Antigen
Figure 11. Product Picture of CD22 Target Antigen
Figure 12. Product Picture of CD33 Target Antigen
Figure 13. Product Picture of Nectin-4 Target Antigen
Figure 14. Product Picture of Others
Figure 15. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type in 2021
Figure 16. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2017-2022)
Figure 17. Monoclonal Antibody ADC Drugs Consumed in Lymphoma
Figure 18. Global Monoclonal Antibody ADC Drugs Market: Lymphoma (2017-2022) & (K Units)
Figure 19. Monoclonal Antibody ADC Drugs Consumed in Breast Cancer
Figure 20. Global Monoclonal Antibody ADC Drugs Market: Breast Cancer (2017-2022) & (K Units)
Figure 21. Monoclonal Antibody ADC Drugs Consumed in Leukemia
Figure 22. Global Monoclonal Antibody ADC Drugs Market: Leukemia (2017-2022) & (K Units)
Figure 23. Monoclonal Antibody ADC Drugs Consumed in Myeloma
Figure 24. Global Monoclonal Antibody ADC Drugs Market: Myeloma (2017-2022) & (K Units)
Figure 25. Monoclonal Antibody ADC Drugs Consumed in Others
Figure 26. Global Monoclonal Antibody ADC Drugs Market: Others (2017-2022) & (K Units)
Figure 27. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2017-2022)
Figure 28. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application in 2021
Figure 29. Monoclonal Antibody ADC Drugs Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Company in 2021
Figure 31. Global Monoclonal Antibody ADC Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Geographic Region in 2021
Figure 33. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2017-2022)
Figure 34. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Country/Region in 2021
Figure 35. Americas Monoclonal Antibody ADC Drugs Sales 2017-2022 (K Units)
Figure 36. Americas Monoclonal Antibody ADC Drugs Revenue 2017-2022 ($ Millions)
Figure 37. APAC Monoclonal Antibody ADC Drugs Sales 2017-2022 (K Units)
Figure 38. APAC Monoclonal Antibody ADC Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Europe Monoclonal Antibody ADC Drugs Sales 2017-2022 (K Units)
Figure 40. Europe Monoclonal Antibody ADC Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Monoclonal Antibody ADC Drugs Sales 2017-2022 (K Units)
Figure 42. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue 2017-2022 ($ Millions)
Figure 43. Americas Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2021
Figure 44. Americas Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2021
Figure 45. United States Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Monoclonal Antibody ADC Drugs Sales Market Share by Region in 2021
Figure 50. APAC Monoclonal Antibody ADC Drugs Revenue Market Share by Regions in 2021
Figure 51. China Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2021
Figure 58. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2021
Figure 59. Germany Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country in 2021
Figure 66. Egypt Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Monoclonal Antibody ADC Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Monoclonal Antibody ADC Drugs in 2021
Figure 72. Manufacturing Process Analysis of Monoclonal Antibody ADC Drugs
Figure 73. Industry Chain Structure of Monoclonal Antibody ADC Drugs
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets